GMAB Genmab A/S
Healthcare$26.87-0.67%ClosedMarket Cap: $16.50B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$37.88
Target (Median)
$39.00
Target Range
$32.00 - $41.50
Upside from current price: 41.0%
Rating Distribution
0 Strong Buy9 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-23 | Guggenheim | maintain | Buy | Buy |
| 2026-02-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-07 | Truist Securities | maintain | Buy | Buy |
| 2025-10-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-24 | Guggenheim | upgrade | Buy | Neutral |
| 2025-08-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-07-08 | Truist Securities | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $1.69 | $5.12B | 9 |
| Sun Dec 31 | $2.57 | $6.22B | 15 |
| Mon Dec 31 | $2.35 | $6.22B | 10 |
| Tue Dec 31 | $2.64 | $6.59B | 6 |